Use of inhibitors of angiotensin converting enzyme in patients with acute myocardial infarction

Kardiologiya

Volumn 37, Issue 3, 1997, Pages 100-104

  Preobrazhensky, D V ^a   Sidorenko, B A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 3342912363     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Reyes A.J.Angiotensin-converting enzyme inhibitors in the clinical setting of chronic congestive heart failure. Am J Cardiol 1995;75:16:50F-55F.
2. Opie L.H. Fundamental role of angiotensin-converting enzyme inhibitors in the management of congestive heart failure. Ibid;3F-6F.
3. Swedberg K., Sharpe N. The value of angiotensin converting enzyme inhibitors for the treatment of patients with left ventricular dysfunction heart failure or after acute myocardial infarction. Eur Heart J 1996;17:9:1306-1311.
4. Sharpe N., Smith H., Murphy J., Hannan S. Treatment of patient with symptomless left ventricular dysfunction after myocardial infarction. Lancet 1988;1:8580:255-259.
5. Pfeffer M.A., Lamas G.A., Vanghan D.E. et al. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. New Engl J Med 1988;319:2:80-86.
6. Pfeffer M.A., Braunwald E., Moye L.A. et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. New Engl J Med 1992;327:10:669-677.
7. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:8875:821-828.
8. Swedberg K., Held P., Kjekshus J. et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II).New Engl J Med 1992;327:10:678-684.
9. Søgaard P., Nøgaard A., Gøtzsche C.O. et al. Therapeutic effects of captopril on ischemia and dysfunction of the left ventricle after Q-wave and non-Q-wave myocardial infarction. Am Heart J 1994;127:1:1-7.
10. Kingma J.H., van Gilst W.H., Peels K.H. et al. Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction. Results from the captopril and Thrombolysis Study (CATS). Eur Heart J 1994;15:5:898 -907.
11. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:8906:1115-1122.
12. ISIS-4 (Fourth International Study of Infarct Survival Collaborative Group.) ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 1994;345:8951:669-685.
13. Ambrosioni E., Borghi C., Magnani B. et al. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. New Engl J Med 1995;332:2:80-85.
14. Chinese Cardiac Study Collaborative Group. Oral captopril versus placebo among 13634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1). Lancet 1995;345:8951:686-687.
15. Kober L., Torp-Pedersen C., Carlsen J.E. et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial in farction. New Engl J Med 1995;333:25:1670-1676.
16. Latini R., Maggioni A.P. ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. Circulation 1995;92:10:3132-3137.